Victory Capital Management Inc Genfit S.A. Transaction History

Victory Capital Management Inc

  • $98.4 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 04, 2020
SELL
$13.55 - $20.14 $2.77 Million - $4.12 Million
-204,730 Closed
0 $0
Q3 2019

Nov 12, 2019
BUY
$14.92 - $19.94 $2.1 Million - $2.8 Million
140,600 Added 219.24%
204,730 $3.56 Million
Q2 2019

Aug 15, 2019
SELL
$19.74 - $25.65 $673,528 - $875,178
-34,120 Reduced 34.73%
64,130 $1.27 Million
Q1 2019

May 03, 2019
BUY
$22.17 - $24.0 $2.18 Million - $2.36 Million
98,250 New
98,250 $2.36 Million

Others Institutions Holding GNFT

# of Institutions
7
Shares Held
76.8K
Call Options Held
0
Put Options Held
0
View Full List

About Genfit S.A.

GNFT Quotes by TradingView
  • Ticker GNFT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,815,500
  • Market Cap $207M
  • Description
  • Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...
More about GNFT
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email